Skip to main content
Erschienen in: Acta Diabetologica 6/2013

01.12.2013 | Original Article

MicroRNA genetic variations: association with type 2 diabetes

verfasst von: Cinzia Ciccacci, Davide Di Fusco, Laura Cacciotti, Roberto Morganti, Cinzia D’Amato, Carla Greco, Sara Rufini, Giuseppe Novelli, Federica Sangiuolo, Vincenza Spallone, Paola Borgiani

Erschienen in: Acta Diabetologica | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs are small single-stranded molecules that have emerged as important genomic regulators in different pathways. Different studies have shown that they are implicated in the metabolism and glucose homeostasis, and therefore, they could also be involved in the pathogenesis of metabolic disorders such as type 2 diabetes (T2DM). The aim of this study was to verify whether genetic variations in candidate microRNA (miRNA or miR) genes could contribute to T2DM susceptibility. We have selected 13 miRNAs as candidate loci according to literature data and to a computational analysis. MicroRNA genes were analyzed by direct sequencing in a cohort of 163 Italian T2DM patients and 185 healthy controls. We identified 6 novel variants never described before and 9 SNPs already described in databases. Five newly identified variants were found only in the cases group. We performed a case/control association study to test the associations of particular alleles/genotypes of identified SNPs with the disease. Two polymorphisms were associated with T2DM susceptibility: in particular, the G allele of rs895819 in hsa-mir-27a has shown a significantly protective effect (OR = 0.58 and P = 0.008), while the G allele of rs531564 in hsa-mir-124a appears to be a risk allele (OR = 2.15, P = 0.008). This is the first report indicating that genetic polymorphisms in miRNA regions could contribute to T2DM susceptibility.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Muhonen P, Holthofer H (2009) Epigenetic and microRNA-mediated regulation in diabetes. Nephrol Dial Transplant 24(4):1088–1096PubMedCrossRef Muhonen P, Holthofer H (2009) Epigenetic and microRNA-mediated regulation in diabetes. Nephrol Dial Transplant 24(4):1088–1096PubMedCrossRef
2.
Zurück zum Zitat Rottiers V, Näär AM (2012) MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13(4):239–250PubMedCrossRef Rottiers V, Näär AM (2012) MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13(4):239–250PubMedCrossRef
3.
Zurück zum Zitat Heneghan HM, Miller N, Kerin MJ (2010) Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 11(5):354–361PubMedCrossRef Heneghan HM, Miller N, Kerin MJ (2010) Role of microRNAs in obesity and the metabolic syndrome. Obes Rev 11(5):354–361PubMedCrossRef
4.
Zurück zum Zitat Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15–20PubMedCrossRef Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120(1):15–20PubMedCrossRef
5.
Zurück zum Zitat Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N (2005) Combinatorial microRNA target predictions. Nat Genet 37(5):495–500PubMedCrossRef Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N (2005) Combinatorial microRNA target predictions. Nat Genet 37(5):495–500PubMedCrossRef
6.
Zurück zum Zitat Fernandez-Valverde SL, Taft RJ, Mattick JS (2011) MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes 60(7):1825–1831PubMedCrossRef Fernandez-Valverde SL, Taft RJ, Mattick JS (2011) MicroRNAs in β-cell biology, insulin resistance, diabetes and its complications. Diabetes 60(7):1825–1831PubMedCrossRef
7.
Zurück zum Zitat Kim YJ, Hwang SJ, Bae YC, Jung JS (2009) MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27:3093–3102PubMed Kim YJ, Hwang SJ, Bae YC, Jung JS (2009) MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27:3093–3102PubMed
8.
Zurück zum Zitat Betel D, Wilson M, Gabow A, Marks DS, Sander C. (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36(Database Issue): D149–53 Betel D, Wilson M, Gabow A, Marks DS, Sander C. (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36(Database Issue): D149–53
9.
Zurück zum Zitat Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432(7014):226–230PubMedCrossRef Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432(7014):226–230PubMedCrossRef
10.
Zurück zum Zitat Li Y, Xu X, Liang Y, Liu S, Xiao H, Li F, Cheng H, Fu Z (2010) miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression. Int J Clin Exp Pathol 3:254–264PubMed Li Y, Xu X, Liang Y, Liu S, Xiao H, Li F, Cheng H, Fu Z (2010) miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression. Int J Clin Exp Pathol 3:254–264PubMed
11.
Zurück zum Zitat Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R (2006) MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 281(37):26932–26942PubMedCrossRef Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R (2006) MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 281(37):26932–26942PubMedCrossRef
12.
Zurück zum Zitat Ciccacci C, Di Fusco D, Cacciotti L, Morganti R, D’Amato C, Novelli G, Sangiuolo F, Spallone V, Borgiani P. (2012) TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol. doi:10.1007/s00592-012-0418-x Ciccacci C, Di Fusco D, Cacciotti L, Morganti R, D’Amato C, Novelli G, Sangiuolo F, Spallone V, Borgiani P. (2012) TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol. doi:10.​1007/​s00592-012-0418-x
13.
Zurück zum Zitat Baroukh N, Ravier MA, Loder MK, Hill EV, Bounacer A, Scharfmann R, Rutter GA, Van Obberghen E (2007) MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 282(27):19575–19588PubMedCrossRef Baroukh N, Ravier MA, Loder MK, Hill EV, Bounacer A, Scharfmann R, Rutter GA, Van Obberghen E (2007) MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 282(27):19575–19588PubMedCrossRef
14.
Zurück zum Zitat Lovis P, Gattesco S, Regazzi R (2008) Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 389(3):305–312PubMedCrossRef Lovis P, Gattesco S, Regazzi R (2008) Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 389(3):305–312PubMedCrossRef
15.
Zurück zum Zitat Gauthier BR, Wollheim CB (2006) MicroRNAs: ‘ribo-regulators’ of glucose homeostasis. Nat Med 12(1):36–38PubMedCrossRef Gauthier BR, Wollheim CB (2006) MicroRNAs: ‘ribo-regulators’ of glucose homeostasis. Nat Med 12(1):36–38PubMedCrossRef
16.
Zurück zum Zitat Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, Mohan V (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem 351(1–2):197–205PubMedCrossRef Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, Mohan V (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem 351(1–2):197–205PubMedCrossRef
17.
Zurück zum Zitat Herrera BM, Lockstone HE, Taylor JM, Wills QF, Kaisaki PJ, Barrett A, Camps C, Fernandez C, Ragoussis J, Gauguier D, McCarthy MI, Lindgren CM (2009) MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 diabetes. BMC Med Genomics 2:54PubMedCrossRef Herrera BM, Lockstone HE, Taylor JM, Wills QF, Kaisaki PJ, Barrett A, Camps C, Fernandez C, Ragoussis J, Gauguier D, McCarthy MI, Lindgren CM (2009) MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 diabetes. BMC Med Genomics 2:54PubMedCrossRef
18.
Zurück zum Zitat John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human MicroRNA targets. PLoS Biol 2(11):e363PubMedCrossRef John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human MicroRNA targets. PLoS Biol 2(11):e363PubMedCrossRef
19.
Zurück zum Zitat Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36(Database issue):D154–8 Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36(Database issue):D154–8
20.
Zurück zum Zitat Lall S, Grün D, Krek A, Chen K, Wang YL, Dewey CN, Sood P, Colombo T, Bray N, Macmenamin P, Kao HL, Gunsalus KC, Pachter L, Piano F, Rajewsky N (2006) A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol 16(5):460–471PubMedCrossRef Lall S, Grün D, Krek A, Chen K, Wang YL, Dewey CN, Sood P, Colombo T, Bray N, Macmenamin P, Kao HL, Gunsalus KC, Pachter L, Piano F, Rajewsky N (2006) A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol 16(5):460–471PubMedCrossRef
21.
Zurück zum Zitat Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, Lee YS, Kim JB (2010) miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 392(3):323–328PubMedCrossRef Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, Lee YS, Kim JB (2010) miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 392(3):323–328PubMedCrossRef
22.
Zurück zum Zitat Sun Q, Gu H, Zeng Y, Xia Y, Wang Y, Jing Y, Yang L, Wang B (2010) Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 101(10):2241–2247PubMedCrossRef Sun Q, Gu H, Zeng Y, Xia Y, Wang Y, Jing Y, Yang L, Wang B (2010) Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci 101(10):2241–2247PubMedCrossRef
23.
Zurück zum Zitat McGregor RA, Choi MS (2011) MicroRNAs in the regulation of adipogenesis and obesity. Curr Mol Med 11(4):304–316PubMedCrossRef McGregor RA, Choi MS (2011) MicroRNAs in the regulation of adipogenesis and obesity. Curr Mol Med 11(4):304–316PubMedCrossRef
24.
Zurück zum Zitat Baroukh NN, Van Obberghen E (2009) Function of microRNA-375 and microRNA-124a in pancreas and brain. FEBS J 276(22):6509–6521PubMedCrossRef Baroukh NN, Van Obberghen E (2009) Function of microRNA-375 and microRNA-124a in pancreas and brain. FEBS J 276(22):6509–6521PubMedCrossRef
25.
Zurück zum Zitat Qi L, Hu Y, Zhan Y, Wang J, Wang BB, Xia HF, Ma X (2012) A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer’s disease in a Mongolian population. Neurosci Lett 515(1):1–6PubMed Qi L, Hu Y, Zhan Y, Wang J, Wang BB, Xia HF, Ma X (2012) A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer’s disease in a Mongolian population. Neurosci Lett 515(1):1–6PubMed
Metadaten
Titel
MicroRNA genetic variations: association with type 2 diabetes
verfasst von
Cinzia Ciccacci
Davide Di Fusco
Laura Cacciotti
Roberto Morganti
Cinzia D’Amato
Carla Greco
Sara Rufini
Giuseppe Novelli
Federica Sangiuolo
Vincenza Spallone
Paola Borgiani
Publikationsdatum
01.12.2013
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 6/2013
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-013-0469-7

Weitere Artikel der Ausgabe 6/2013

Acta Diabetologica 6/2013 Zur Ausgabe

Consensus Paper

Trialogue Plus

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.